Literature DB >> 18670825

FLT-PET imaging of radiation responses in murine tumors.

M H Pan1, S C Huang, Y P Liao, D Schaue, C C Wang, D B Stout, J R Barrio, W H McBride.   

Abstract

BACKGROUND: 3'-[F-18]fluoro-3'-deoxythymidine (FLT) traces thymidine phosphorylation catalyzed by thymidine kinase during cell proliferation. Knowing the rate of cell proliferation during cancer treatment, such as radiation therapy, would be valuable in assessing whether tumor recurrence is likely and might indicate the need for additional treatments. However, the relationship between FLT kinetics and the effects of radiation is not well-understood. Nor has the method for optimal quantification of FLT uptake within the irradiated tumor microenvironment been extensively examined.
MATERIALS AND METHODS: We performed dynamic FLT-positron emission tomography (PET) studies (60 min) on 22 mice implanted subcutaneously with syngeneic mammary MCaK tumors bilaterally in the shoulder area. A day before the FLT-PET imaging, the tumor on the right side was irradiated with a single dose (0, 2.5, 5, 10, or 20 Gy) or with fractionated exposures (4x2.5 Gy given in 12 h intervals). Standardized uptake value (SUVs) of FLT on tumors at 10 and 60 min post injection were calculated; model fitting was used to estimate the kinetic parameters. Significant radiation-induced changes were shown by comparing the irradiated tumor with the control tumor in the same animal and by comparing it to nonirradiated mice. The effect of radiation on MCaK cell cycle parameters and FLT uptake was also examined in vitro.
RESULTS: In vivo FLT kinetics were sensitive to radiation doses of 5 Gy and higher (administered 1 day earlier), as judged by SUV semiquantitative measures and by modeling. Single irradiation with 10 Gy had greater impact on SUVs and kinetic parameters than fractionated exposures. Overall, the uptake constant Ki appeared to be the best marker for these radiation effects. FLT uptake by irradiated cells in vitro at various doses gave similar findings, and the in vitro FLT uptake correlated well with Ki. Radiation-induced G2/M arrest appeared to influence FLT uptake, and this was more pronounced after single than fractionated doses.
CONCLUSION: The kinetics of FLT uptake into murine mammary tumors was altered 1 day after radiation treatment. The dose-dependent response correlated well with in vitro FLT cellular uptake. Parameters (e.g., Ki) derived from FLT kinetics are expected to be useful for assessing the efficacy of irradiation treatment of tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670825      PMCID: PMC2696488          DOI: 10.1007/s11307-008-0158-z

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  41 in total

1.  Anatomy of SUV. Standardized uptake value.

Authors:  S C Huang
Journal:  Nucl Med Biol       Date:  2000-10       Impact factor: 2.408

Review 2.  [18F]FLT-PET in oncology: current status and opportunities.

Authors:  Lukas B Been; Albert J H Suurmeijer; David C P Cobben; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

Review 3.  Screening for cancer with PET and PET/CT: potential and limitations.

Authors:  Heiko Schöder; Mithat Gönen
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

4.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

Review 5.  PET imaging of cellular proliferation.

Authors:  David A Mankoff; Anthony F Shields; Kenneth A Krohn
Journal:  Radiol Clin North Am       Date:  2005-01       Impact factor: 2.303

6.  In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device.

Authors:  Hsiao-Ming Wu; Guodong Sui; Cheng-Chung Lee; Mayumi L Prins; Waldemar Ladno; Hong-Dun Lin; Amy S Yu; Michael E Phelps; Sung-Cheng Huang
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

7.  The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1.

Authors:  Min Ho Jeong; Young Hee Jin; Eun Young Kang; Wol Soon Jo; Hwan Tae Park; Jae Dong Lee; Yeo Jin Yoo; Soo Jin Jeong
Journal:  Cell Res       Date:  2004-08       Impact factor: 25.617

8.  Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.

Authors:  X B Kong; Q Y Zhu; P M Vidal; K A Watanabe; B Polsky; D Armstrong; M Ostrander; S A Lang; E Muchmore; T C Chou
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

9.  Early changes in [18F]FLT uptake after chemotherapy: an experimental study.

Authors:  Helmut Dittmann; Bernhard Matthias Dohmen; Rainer Kehlbach; Gabi Bartusek; Maren Pritzkow; Mario Sarbia; Roland Bares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-09-06       Impact factor: 9.236

10.  Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.

Authors:  K Kubota; K Ishiwata; R Kubota; S Yamada; M Tada; T Sato; T Ido
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

View more
  9 in total

Review 1.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  Evaluation of a multi-pinhole collimator for imaging small animals with different sizes.

Authors:  Greta S P Mok; Jianhua Yu; Yong Du; Yuchuan Wang; Benjamin M W Tsui
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

Review 3.  Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.

Authors:  Giampaolo Tomasi; Federico Turkheimer; Eric Aboagye
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

Review 4.  Dynamic whole-body PET imaging: principles, potentials and applications.

Authors:  Arman Rahmim; Martin A Lodge; Nicolas A Karakatsanis; Vladimir Y Panin; Yun Zhou; Alan McMillan; Steve Cho; Habib Zaidi; Michael E Casey; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

Review 5.  Molecular imaging in cancer treatment.

Authors:  Mark H Michalski; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

Review 6.  Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.

Authors:  Mark P S Dunphy; Jason S Lewis
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

7.  Cellular autofluorescence following ionizing radiation.

Authors:  Dörthe Schaue; Josephine A Ratikan; Keisuke S Iwamoto
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone.

Authors:  Ioannis Trigonis; Pek Keng Koh; Ben Taylor; Mahbubunnabi Tamal; David Ryder; Mark Earl; Jose Anton-Rodriguez; Kate Haslett; Helen Young; Corinne Faivre-Finn; Fiona Blackhall; Alan Jackson; Marie-Claude Asselin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-07       Impact factor: 9.236

9.  Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft.

Authors:  Naoyuki Ukon; Songji Zhao; Wenwen Yu; Yoichi Shimizu; Ken-Ichi Nishijima; Naoki Kubo; Yoshimasa Kitagawa; Nagara Tamaki; Kei Higashikawa; Hironobu Yasui; Yuji Kuge
Journal:  EJNMMI Res       Date:  2016-12-12       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.